Showing results (1631-1640 of 1,669) with videos related to

Sort By:
Pageof 167
Innovations (Philadelphia, Pa.)|September 23, 2016
Minimally Invasive Mitral Valve Surgery I: Patient Selection, Evaluation, and PlanningGorav Ailawadi, Arvind K Agnihotri, John R Mehall, et al.
The Oncologist|February 10, 2023
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other EtiologiesSurendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, et al.
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
Journal of Medicinal Chemistry|September 9, 2015
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)Kentaro Futatsugi, Daniel W Kung, Suvi T M Orr, et al.
Innovations (Philadelphia, Pa.)|September 23, 2016
Minimally Invasive Mitral Valve Surgery II: Surgical Technique and Postoperative ManagementJ Alan Wolfe, S Chris Malaisrie, R Saeid Farivar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase FusionsHarshabad Singh, Yvonne Y Li, Liam F Spurr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinomaDarrell R Borger, Lipika Goyal, Thomas Yau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal CancersAparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Pageof 167